Navigation Links
Verizon Advances Patient Care With Launch of Mobile Health Software Solution

BASKING RIDGE, N.J., Oct. 24, 2013 /PRNewswire/ -- Addressing yet another critical issue faced by the U.S. healthcare system, Verizon Enterprise Solutions today announced the immediate availability of Converged Health Management, a remote patient-monitoring medical platform designed to help clinicians and patients manage patients' health in between doctor visits. 

Verizon's newest solution addresses the day-to-day communications gap that has historically existed between patients and clinicians. These gaps may contribute to patient health problems, decreased care compliance, increased emergency room visits and longer hospital stays.

The Converged Health Management solution enables patients to use biometric devices to take health information such as blood pressure, oxygen saturation levels, glucose levels and weight from home or on the go. Patient data is then automatically transmitted through a wireless connection to a secure server that resides in Verizon's HIPAA-ready cloud for analysis and intervention by the patient's clinician, including a reward system that incents patients to make healthier lifestyle choices. Patients can access this information and find personalized health-enhancing suggestions via the Converged Health Management smartphone app or Web portal. (See video demo.)

(NOTE: Verizon Enterprise Solutions will hold an audio news conference today at 11 a.m. ET to announce the launch of the Converged Health Management solution. The dial-in number is 1-866-617-1526; 1-210-795-0624; 8217773 passcode.)

As part of their health program, patients can take advantage of related health information, including videos and webinars. In addition, patients can connect anonymously with other patients in a secure "social networking" environment, where they can ask questions, and share ideas and experiences.  

Converged Health Management is available for purchase by U.S. health insurance companies, integrated delivery networks, hospitals, and large provider groups and self-funded employers that are looking for ways to monitor at-home care compliance, engage patients in healthier lifestyle choices and reduce hospital readmissions.

"Patient outcomes are often the result of what individuals do when they are away from their care providers," said Dr. Peter Tippett, chief medical officer and vice president, Verizon Innovation Incubator. "With this solution, Verizon is helping to transform how healthcare is delivered in the U.S. by increasing patient engagement and empowering patients to better manage their own health."

The launch of Converged Health Management marks another milestone in Verizon's corporate strategy to deliver converged solutions that leverage the company's extensive mobility, cloud and security assets to address big societal challenges.

John Stratton, president, Verizon Enterprise Solutions, said: "More than one-sixth of the U.S. economy is devoted to healthcare spending, and as the industry drives to deliver better care, managing costs is a key focus. Converged Health Management is a perfect example of how we are using our unique combination of assets like our 4G LTE wireless network and cloud infrastructure to deliver an innovative, cost-effective and game-changing solution to the marketplace."

This announcement follows the company's Aug. 8 U.S. Food and Drug Administration 510(k) clearance release.

Verizon Delivers Comprehensive Set of Health IT Solutions  

Verizon provides an integrated fabric of health IT solutions that address the biggest challenges facing the U.S. healthcare system today, including the ability to securely and efficiently exchange sensitive patient data across hospital, payer and physician networks via voice, video and data. This includes interconnected cloud, mobility, machine-to-machine and security solution sets.   

Verizon's vision is to create a healthier world in which connected individuals and healthcare organizations are empowered with innovative technologies that improve health outcomes, transform access to care and lower the cost of healthcare.

Indications For Use

The CHM Device is a remote monitoring software solution intended to collect and store biometric data from physiological measurement devices intended for use in the home. The CHM Device also allows for the automated transmission of the biometric data to a remote secure server via existing mobile telecommunications and/or Internet infrastructure. The stored biometric data is accessible by clinicians for analysis and intervention. Patients can also review the stored biometric data and receive educational and motivational content from clinicians. The CHM Device can be used as a standalone device or in conjunction with supported patient monitoring devices, such as a glucometer, weight scale, pulse oximeter and blood pressure monitor.

The CHM Device is not intended for use in surgical rooms, intensive care units, intermediate or step-down units or emergency vehicles. It is not interpretive, nor is it intended for diagnosis or as a replacement for the oversight of healthcare professionals. It does not provide real-time or emergency monitoring. 

Warnings and Precautions

There is risk that data housed by the CHM Device may become lost or corrupt as a result of a failure of the CHM Device. The risk of loss or corruption of health data in the CHM Device is similar to the risks associated with data storage systems a hospital or clinic might use when storing electronic medical records. Such risks should be understood by users of CHM Device, including clinicians and patients.

Verizon Communications Inc. (NYSE, Nasdaq: VZ), headquartered in New York, is a global leader in delivering broadband and other wireless and wireline communications services to consumer, business, government and wholesale customers. Verizon Wireless operates America's most reliable wireless network, with more than 101 million retail connections nationwide. Verizon also provides converged communications, information and entertainment services over America's most advanced fiber-optic network, and delivers integrated business solutions to customers in more than 150 countries. A Dow 30 company with nearly $116 billion in 2012 revenues, Verizon employs a diverse workforce of 178,300.  For more information, visit

Verizon Enterprise Solutions Online News Center: News releases, blog posts, media contacts and other information are available in Verizon Enterprise Solutions' online News Center at  News from Verizon Enterprise Solutions is also available through an RSS feed at

SOURCE Verizon
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Advances in temporal forensic investigations
2. New gene repair technique promises advances in regenerative medicine
3. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
4. New sickle cell anemia therapy advances to Phase II clinical trials
5. New advances in the management of patients with cirrhosis
6. Research advances therapy to protect against dengue virus
7. Discovery of first motor with revolution motion in a virus-killing bacteria advances nanotechnology
8. IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management
9. Discovery of 100 million-year-old regions of DNA shows short cut to crop science advances
10. Study advances use of stem cells in personalized medicine
11. Geologist calls for advances in restoration sedimentology
Post Your Comments:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... JOLLA, Calif. , Oct. 29, 2015  The ... a new report titled, "DNA Synthesis and Biosecurity: Lessons ... well the Department of Health and Human Services guidance ... issued in 2010. --> ... but it also has the potential to pose unique ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology: